Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers
Bhoj R Singh Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, IndiaIn a recently published article1 moxalactam has been claimed to be very effective on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae, concluding “MOX demons...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2018-03-01
|
| Serie: | Infection and Drug Resistance |
| Soggetti: | |
| Accesso online: | https://www.dovepress.com/moxalactam-is-not-more-active-on-extended-spectrum-beta-lactamase-esbl-peer-reviewed-article-IDR |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|